Concetta Scazzone1, Luisa Agnello1, Paolo Ragonese2, Bruna Lo Sasso1, Chiara Bellia1, Giulia Bivona1, Rosaria Schillaci1, Giuseppe Salemi2, Marcello Ciaccio1,3. 1. Section of Clinical Biochemistry and Clinical Molecular Medicine, Department of Biopathology and Medical Biotechnologies, University of Palermo, Via del Vespro 129, 90127, Italy. 2. Department of Experimental Biomedicine and Neuroscience, University of Palermo, Via del Vespro 129, 90127, Italy. 3. UOC of Laboratory Medicine, AOUP "P. Giaccone", University of Palermo, Via del Vespro 129, 90127, Palermo, Italy.
Abstract
BACKGROUND: MS is a neurodegenerative autoimmune disease resulting from a complex interaction of genetic and environmental factors. Among these, vitamin D and genetic variants associated with vitamin D-metabolism gain great attention. The aim of our study was to assess five SNPs in NADSYN1 and CYP2R1 genes in relation to serum 25-OH-vitamin D3 levels in MS patients and controls. METHODS: 25-OH-vitamin D3 levels and genotyping of CYP2R1- and NADSYN1-SNPs were investigated both in MS patients and in healthy controls. RESULTS: The analysis revealed lower 25-OH-vitamin D3 concentrations in MS patients than in controls and an association of rs10766197 CYP2R1 SNP with MS risk. After stratifying MS patients according to gender, we found that the minor allele A of rs10766197 had a higher frequency in men in comparison to women affected by MS. Additionally, the presence of allele A in men was associated with disease progression, assessed by EDSS and MSSS scores. CONCLUSION: The findings of our study open new perspectives for a role of CYP2R1 in both risk and progression of MS, with sex-related differences.
BACKGROUND: MS is a neurodegenerative autoimmune disease resulting from a complex interaction of genetic and environmental factors. Among these, vitamin D and genetic variants associated with vitamin D-metabolism gain great attention. The aim of our study was to assess five SNPs in NADSYN1 and CYP2R1 genes in relation to serum 25-OH-vitamin D3 levels in MS patients and controls. METHODS:25-OH-vitamin D3 levels and genotyping of CYP2R1- and NADSYN1-SNPs were investigated both in MS patients and in healthy controls. RESULTS: The analysis revealed lower 25-OH-vitamin D3 concentrations in MS patients than in controls and an association of rs10766197CYP2R1 SNP with MS risk. After stratifying MS patients according to gender, we found that the minor allele A of rs10766197 had a higher frequency in men in comparison to women affected by MS. Additionally, the presence of allele A in men was associated with disease progression, assessed by EDSS and MSSS scores. CONCLUSION: The findings of our study open new perspectives for a role of CYP2R1 in both risk and progression of MS, with sex-related differences.
Authors: Enrique González-Madrid; Ma Andreina Rangel-Ramírez; María José Mendoza-León; Oscar Álvarez-Mardones; Pablo A González; Alexis M Kalergis; Ma Cecilia Opazo; Claudia A Riedel Journal: Int J Mol Sci Date: 2022-06-25 Impact factor: 6.208
Authors: Monika Chorąży; Natalia Wawrusiewicz-Kurylonek; Edyta Adamska-Patruno; Olga Zajkowska; Katarzyna Kapica-Topczewska; Renata Posmyk; Adam Jacek Krętowski; Jan Kochanowicz; Alina Kułakowska Journal: J Immunol Res Date: 2020-11-11 Impact factor: 4.818
Authors: Emmanuelle Waubant; Robyn Lucas; Ellen Mowry; Jennifer Graves; Tomas Olsson; Lars Alfredsson; Annette Langer-Gould Journal: Ann Clin Transl Neurol Date: 2019-08-07 Impact factor: 4.511
Authors: Jean-Pierre Rothen; Jonas Rutishauser; Philipp N Walter; Kurt E Hersberger; Isabelle Arnet Journal: BMC Pharmacol Toxicol Date: 2020-07-11 Impact factor: 2.483